Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

NCT03614832 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Platelet Reactivity

Interventions

DRUG: Ticagrelor 90 mg
DRUG: Clopidogrel 150 mg

Sponsor

First Affiliated Hospital of Harbin Medical University